BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...

May 21 (Reuters) - Mayne Pharma shares (MYX.AX), opens new tab posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 ...

Bridgewater-based Cosette issued a statement Dec. 11 saying it served a notice to the Australia-headquartered pharmaceutical company two days prior terminating the agreement. The deal was originally ...

While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of ...

Avista made its initial investment in Cosette in December 2018 Ropes & Gray LLP advised Avista Capital Partners and Cosette Pharmaceuticals on this transaction and Debevoise & Plimpton LLP advised ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...